The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 741 Metabolic Health articles
The rise of GLP-1 medications is no longer a whisper; it's a culinary revolution. From shrinking appetites to evolving tastes, these powerful drugs are prompting a significant shift in how we eat out, forcing restaurants to adapt their offerings and dining strategies.
The emergence of GLP-1 receptor agonists has revolutionized obesity treatment, but concerns about weight regain upon discontinuation are significant. New research on duodenal mucosal resurfacing suggests a potential breakthrough in maintaining weight loss long-term.
A groundbreaking discovery using artificial intelligence has identified a naturally occurring molecule, BRP, that targets the brain's appetite center, potentially offering a new and improved alternative for weight management compared to current GLP-1 medications.
Significant weight loss, often achieved with medications like GLP-1 agonists, can bring about transformative health benefits but also raises questions about changes in appearance. This article delves into the phenomenon of 'Mounjaro face,' discusses how to approach sensitive conversations about appearance with friends and family, and offers practical advice for maintaining well-being during and after weight loss.
Athletes are increasingly curious about peptides for performance enhancement and recovery. This article delves into the scientific literature to separate the hype from the reality, examining the evidence for popular peptides and their potential risks.
While GLP-1 medications are celebrated for weight loss and reduced food noise, some users report emotional flattening. This article delves into the 'Ozempic personality' phenomenon, its potential causes, and expert perspectives on managing these psychological shifts.
New research suggests an outpatient endoscopic procedure could help patients maintain weight loss after discontinuing GLP-1 medications like Wegovy and Mounjaro.
A groundbreaking Johns Hopkins study reveals that severe obesity causes intrinsic cardiac muscle weakness, but weight loss can trigger significant recovery.
New data shows many patients cycle on and off GLP-1 medications. Discover why this approach may hinder long-term health and why tracking is essential.
